Title:
CYCLOALKYL OR HETEROCYCLYL SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/165570
Kind Code:
A1
Abstract:
The present invention relates to a compound of formula (I) or a tautomer, stereoisomer, prodrug, crystal form, pharmaceutically acceptable salt, hydrate, or solvate thereof, a pharmaceutical composition thereof, and a use of the compound, the tautomer, stereoisomer, prodrug, crystal form, pharmaceutically acceptable salt, hydrate, or solvate thereof, and the pharmaceutical composition thereof in the treatment and/or prevention of wild and/or mutated BTK kinase-mediated diseases.
More Like This:
| WO/2012/165547 | METHOD FOR MANUFACTURING PYRAZOLE DERIVATIVE |
| WO/2001/047475 | AGENT FOR DYEING KERATIN CONTAINING FIBERS |
| WO/2017/081014 | PROCESS FOR THE PREPARATION OF ELTROMBOPAG OLAMINE |
Inventors:
WANG YIHAN (CN)
LI HUANYIN (CN)
AI YIXIN (CN)
LI HUANYIN (CN)
AI YIXIN (CN)
Application Number:
PCT/CN2023/079360
Publication Date:
September 07, 2023
Filing Date:
March 02, 2023
Export Citation:
Assignee:
SHENZHEN TARGETRX INC (CN)
International Classes:
C07D231/38; A61K31/437; A61K31/519; A61K31/522; A61K31/53; A61P19/02; A61P29/00; A61P35/00; A61P35/02; A61P37/02; C07D471/04; C07D487/04
Foreign References:
| CN114075190A | 2022-02-22 | |||
| CN108431007A | 2018-08-21 | |||
| CN114380820A | 2022-04-22 | |||
| CN114573586A | 2022-06-03 | |||
| CN115707705A | 2023-02-21 | |||
| US20220169645A1 | 2022-06-02 | |||
| CN109851620A | 2019-06-07 | |||
| CN109111439A | 2019-01-01 |
Attorney, Agent or Firm:
LIU , SHEN & ASSOCIATES (CN)
Download PDF: